Spatial learning deficit in transgenic mice that conditionally over‐express GSK‐3β in the brain but do not form tau filaments

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurochemistry

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.2002.01269.xPMID 12472906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

  2004cited by this paper
• First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

  2002cited by this paper
• Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

  2002cited by this paper
• Tau is essential to β-amyloid-induced neurotoxicity

  2002cited by this paper
• Tau is essential to beta -amyloid-induced neurotoxicity.

  2002cited by this paper
• Glycogen synthase kinase 3: an emerging therapeutic target.

  2002cited by this paper
• Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death

  2001cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

  2001cited by this paper
• Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice

  2001cited by this paper
• Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease

  2001cited by this paper
• Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

  2001cited by this paper
• FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.

  2001cited by this paper
• Huntington's disease: the challenge for cell biologists.

  2000cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• Nuclear localization of beta-catenin in adult mouse thalamus correlates with low levels of GSK-3beta.

  1999cited by this paper
• Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration

  1999cited by this paper
• Nuclear localization of β-catenin in adult mouse thalamus correlates with low levels of GSK-3β

  1999cited by this paper
• Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes

  1999cited by this paper
• Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration.

  1999cited by this paper
• Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

  1999cited by this paper
• Genetic neurodegenerative diseases: the human illness and transgenic models.

  1998cited by this paper
• Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

  1998cited by this paper
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

  1997cited by this paper
• Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

  1997influential reference
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta.

  1996cited by this paper
• Glycogen synthase kinase 3 phosphorylation of different residues in the presence of different factors: Analysis on tau protein

  1996cited by this paper
• Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II

  1996influential reference
• Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β

  1996cited by this paper
• Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

  1994cited by this paper
• Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.

  1994cited by this paper
• Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

  1993cited by this paper
• Tau protein I is essential for amyloid β-protein iduced neurotoxicity

  1993cited by this paper

• Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review

  2026cites this paper
• Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer’s disease-like pathology: modulatory effects of CCR5 antagonists

  2025cites this paper
• The Ubiquitin–Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers

  2025cites this paper
• Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure‐Activity Relationships

  2025cites this paper
• Polyphenols as Wnt/β‐catenin pathway modulators: A promising strategy in clinical neurodegeneration

  2025cites this paper
• Is tau pathology a relevant factor in neuronal damage induced by alcohol and other drugs?

  2025cites this paper
• Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach

  2025cites this paper
• Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease

  2025cites this paper
• ERRα and ERRγ coordinate expression of genes associated with Alzheimer’s disease, inhibiting DKK1 to suppress tau phosphorylation

  2024cites this paper
• GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model

  2024cites this paper
• Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease

  2024cites this paper
• Delivery of AKT1 phospho‐forms to human cells reveals differential substrate selectivity

  2024cites this paper
• GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filaments

  2024cites this paper
• Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation

  2024cites this paper
• Role and Regulation of Glycogen Synthase Kinase-3 in Obesity-Associated Metabolic Perturbations

  2024cites this paper
• Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.

  2024cites this paper
• Editorial: The protein kinase GSK3 in neurobiological functions and neuronal disorders

  2023cites this paper
• GSK3β phosphorylation catalyzes the aggregation of Tau into Alzheimer’s disease-like amyloid strain

  2023cites this paper
• Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease

  2023cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?

  2023influential citation
• Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil

  2023cites this paper
• GSK-3β orchestrates the inhibitory innervation of adult-born dentate granule cells in vivo

  2023cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3 b

  2022cites this paper
• The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway

  2022cites this paper
• Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration

  2022cites this paper
• Ginsenoside and Its Therapeutic Potential for Cognitive Impairment

  2022cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3β

  2022cites this paper
• Redox signaling at the crossroads of human health and disease

  2022cites this paper
• Specific Role for GSK3α in Limiting Long-Term Potentiation in CA1 Pyramidal Neurons of Adult Mouse Hippocampus

  2022cites this paper
• Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine.

  2022cites this paper
• A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro

  2022cites this paper
• Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity

  2022cites this paper
• Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward

  2022cites this paper
• Allantoin ameliorates amyloid β-peptide-induced memory impairment by regulating the PI3K/Akt/GSK-3β signaling pathway in rats.

  2022cites this paper
• The GSK-3 Inhibitor CT99021 Enhances the Acquisition of Spatial Learning and the Accuracy of Spatial Memory

  2022cites this paper
• Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events

  2021cites this paper
• Memory formation in old age requires GSK-3β

  2021cites this paper
• Vortioxetine ameliorates anhedonic-like behaviour and promotes strategic cognitive performance in a rodent touchscreen task

  2021cites this paper
• Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) Inhibitor Attenuates Amyloid β-Induced Cognitive Impairment: Possible Mechanisms

  2021cites this paper
• GSK-3 and Tau: A Key Duet in Alzheimer’s Disease

  2021cites this paper
• Developmental effects of early-life stress on dopamine D2 receptor and proteins involved in noncanonical D2 dopamine receptor signaling pathway in the prefrontal cortex of male rats

  2021cites this paper
• Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice

  2021cites this paper
• Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation

  2021cites this paper
• GSK3β Activity in Reward Circuit Functioning and Addiction

  2021cites this paper
• Effects of sub-chronic caffeine ingestion on memory and the hippocampal Akt, GSK-3β and ERK signaling in mice.

  2021cites this paper
• Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration

  2021cites this paper
• Effects of adropin on learning and memory in rats tested in the Morris water maze

  2021cites this paper
• When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease

  2021cites this paper
• Impaired clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in a mouse model of Alzheimer’s disease

  2021cites this paper
• Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits

  2020cites this paper
• Coenzyme Q in Aging

  2020cites this paper
• Gelsemine, a natural alkaloid extracted from Gelsemium elegans Benth. alleviates neuroinflammation and cognitive impairments in Aβ oligomer-treated mice

  2020cites this paper
• The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.

  2020cites this paper
• Glycogen synthase kinase-3 as a key regulator of cognitive function.

  2020cites this paper
• A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer

  2020cites this paper
• GSK-3β activation is required for ZIP-induced disruption of learned fear

  2020cites this paper
• Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies

  2020cites this paper
• Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

  2020cites this paper
• Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

  2020cites this paper
• Dangerous Liaisons: Tau Interaction with Muscarinic Receptors

  2020cites this paper
• Conditional GSK3β deletion in parvalbumin-expressing interneurons potentiates excitatory synaptic function and learning in adult mice.

  2020cites this paper
• Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice

  2020influential citation
• Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.

  2020cites this paper
• Astaxanthin protects cognitive function of vascular dementia

  2020cites this paper
• Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.

  2020cites this paper
• Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced Memory Dysfunction: A Mechanistic Study

  2020cites this paper
• Nrf2: a dark horse in Alzheimer's disease treatment.

  2020cites this paper
• Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases

  2020cites this paper
• Dopamine D3 receptor and GSK3β signaling mediate deficits in novel object recognition memory within dopamine transporter knockdown mice

  2020cites this paper
• Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action

  2020cites this paper
• Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.

  2019cites this paper
• Potential synaptic plasticity‐based Shenzhiling oral liquid for a SAD Mouse Model

  2019cites this paper
• Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses

  2019cites this paper
• Downregulated lncRNA CRNDE contributes to the enhancement of nerve repair after traumatic brain injury in rats

  2019cites this paper
• An expanding GSK3 network: implications for aging research

  2019cites this paper
• Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function

  2019cites this paper
• Effects of Chronic and Acute Lithium Treatment on the Long-term Potentiation and Spatial Memory in Adult Rats

  2019cites this paper
• Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective

  2019cites this paper
• Early Life Stress and High FKBP5 Interact to Increase Anxiety-Like Symptoms through Altered AKT Signaling in the Dorsal Hippocampus

  2019cites this paper
• Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.

  2019cites this paper
• Wnt Signaling Deregulation in the Aging and Alzheimer’s Brain

  2019cites this paper
• GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration

  2019cites this paper
• The effect of cinnamaldehyde on passive avoidance memory and hippocampal Akt, ERK and GSK-3β in mice.

  2019cites this paper
• Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors

  2019cites this paper
• Glycogen Synthase Kinase 3β in the ventral hippocampus is important for cocaine reward and object location memory.

  2019cites this paper
• MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer's disease.

  2019cites this paper
• High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1–42-induced Alzheimer's disease

  2018cites this paper
• Endoplasmic reticulum stress induces spatial memory deficits by activating GSK‐3

  2018cites this paper
• Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration

  2018cites this paper
• Dual GSK-3 # / AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer ’ s Disease Drug Discovery

  2018cites this paper
• Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus

  2018cites this paper
• Circadian Regulation of Hippocampal-Dependent Memory: Circuits, Synapses, and Molecular Mechanisms

  2018cites this paper
• The Novel DA–CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model

  2018cites this paper
• The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?

  2018cites this paper
• Pharmacological properties and innovative therapeutic targets of novel compounds used to treat major depression

  2018cites this paper
• Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer’s Disease

  2018cites this paper
• The Effects of the Gsk-3 Inhıbıtor Tdzd-8 on Bıpolar-Lıke Behavıoral Phenotype Induced by Hıgh Fructose Corn Syrup Consumptıon in Adolescent Rats

  2018cites this paper
• Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery.

  2018cites this paper
• Mecanismos implicados en la neurodegeneración inducida por dieta grasa en modelos de senescencia

  2018cites this paper